117 related articles for article (PubMed ID: 22102490)
1. Effect of the aromatase inhibitor anastrozole on uterine and leiomyoma Doppler blood flow in patients scheduled for hysterectomy: a pilot study.
Brito LG; Candido-dos-Reis FJ; Magario FA; Sabino-de-Freitas MM
Ultrasound Obstet Gynecol; 2012 Jul; 40(1):119-20. PubMed ID: 22102490
[No Abstract] [Full Text] [Related]
2. A case of benign metastasizing leiomyoma treated by surgical castration followed by an aromatase inhibitor, anastrozole.
Nasu K; Tsuno A; Takai N; Narahara H
Arch Gynecol Obstet; 2009 Feb; 279(2):255-7. PubMed ID: 18523791
[TBL] [Abstract][Full Text] [Related]
3. Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients.
Hilário SG; Bozzini N; Borsari R; Baracat EC
Fertil Steril; 2009 Jan; 91(1):240-3. PubMed ID: 18249392
[TBL] [Abstract][Full Text] [Related]
4. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.
Parsanezhad ME; Azmoon M; Alborzi S; Rajaeefard A; Zarei A; Kazerooni T; Frank V; Schmidt EH
Fertil Steril; 2010 Jan; 93(1):192-8. PubMed ID: 19135657
[TBL] [Abstract][Full Text] [Related]
5. Treatment of symptomatic uterine leiomyoma with letrozole.
Gurates B; Parmaksiz C; Kilic G; Celik H; Kumru S; Simsek M
Reprod Biomed Online; 2008 Oct; 17(4):569-74. PubMed ID: 18854113
[TBL] [Abstract][Full Text] [Related]
6. Metastatic uterine leiomyosarcoma regression using an aromatase inhibitor.
Hardman MP; Roman JJ; Burnett AF; Santin AD
Obstet Gynecol; 2007 Aug; 110(2 Pt 2):518-20. PubMed ID: 17666649
[TBL] [Abstract][Full Text] [Related]
7. Role of the aromatase inhibitor letrozole in the management of uterine leiomyomas in premenopausal women.
Duhan N; Madaan S; Sen J
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):329-32. PubMed ID: 24103533
[TBL] [Abstract][Full Text] [Related]
8. [Surgical treatment of subserosal fibroids: the cons].
Marret H; Ouldamer L
Gynecol Obstet Fertil; 2011; 39(7-8):454-7. PubMed ID: 21752689
[No Abstract] [Full Text] [Related]
9. Combined down-regulation by aromatase inhibitor and GnRH-agonist in IVF patients with endometriomas-A pilot study.
Lossl K; Loft A; Freiesleben NL; Bangsbøll S; Andersen CY; Pedersen AT; Hartwell D; Andersen AN
Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):48-53. PubMed ID: 19261371
[TBL] [Abstract][Full Text] [Related]
10. Regression of tamoxifen-stimulated massive uterine fibroid after conversion to anastrozole.
Attilakos G; Fox R
J Obstet Gynaecol; 2005 Aug; 25(6):609-10. PubMed ID: 16234156
[No Abstract] [Full Text] [Related]
11. Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study.
Hefler LA; Grimm C; van Trotsenburg M; Nagele F
Fertil Steril; 2005 Oct; 84(4):1033-6. PubMed ID: 16213868
[TBL] [Abstract][Full Text] [Related]
12. Effects of letrozole on proliferation and apoptosis in cultured leiomyoma cells treated with prostaglandin E(2).
Han M; Kim JY; Park JE; Kim JM; Lee KS
Eur J Obstet Gynecol Reprod Biol; 2008 May; 138(1):83-8. PubMed ID: 18164802
[TBL] [Abstract][Full Text] [Related]
13. Intravenous leiomyomatosis treated with aromatase inhibitor therapy.
Biri A; Korucuoglu U; Zumrutbas N; Tiras B; Guner H
Int J Gynaecol Obstet; 2008 Jun; 101(3):299-300. PubMed ID: 18280477
[No Abstract] [Full Text] [Related]
14. Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity, and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy.
Wilkens J; Chwalisz K; Han C; Walker J; Cameron IT; Ingamells S; Lawrence AC; Lumsden MA; Hapangama D; Williams AR; Critchley HO
J Clin Endocrinol Metab; 2008 Dec; 93(12):4664-71. PubMed ID: 18765509
[TBL] [Abstract][Full Text] [Related]
15. Effect of anastrozole and tamoxifen on lipid metabolism in Japanese postmenopausal women with early breast cancer.
Sawada S; Sato K; Kusuhara M; Ayaori M; Yonemura A; Tamaki K; Hiraide H; Mochizuki H; Ohsuzu F
Acta Oncol; 2005; 44(2):134-41. PubMed ID: 15788292
[TBL] [Abstract][Full Text] [Related]
16. ACOG practice bulletin. Alternatives to hysterectomy in the management of leiomyomas.
American College of Obstetricians and Gynecologists
Obstet Gynecol; 2008 Aug; 112(2 Pt 1):387-400. PubMed ID: 18669742
[No Abstract] [Full Text] [Related]
17. Ejaculatory sperm production in non-obstructive azoospermic patients with a history of negative testicular biopsy after the administration of an aromatase inhibitor: report of two cases.
Kyrou D; Kosmas IP; Popovic-Todorovic B; Donoso P; Devroey P; Fatemi HM
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():120-1. PubMed ID: 24295732
[No Abstract] [Full Text] [Related]
18. Uterine artery blood flow parameters in women with dysfunctional uterine bleeding and uterine fibroids: the effects of tranexamic acid.
Lakhani KP; Marsh MS; Purcell W; Hardiman P
Ultrasound Obstet Gynecol; 1998 Apr; 11(4):283-5. PubMed ID: 9618854
[TBL] [Abstract][Full Text] [Related]
19. The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study.
Garcia-Velasco JA; Moreno L; Pacheco A; Guillén A; Duque L; Requena A; Pellicer A
Fertil Steril; 2005 Jul; 84(1):82-7. PubMed ID: 16009161
[TBL] [Abstract][Full Text] [Related]
20. Aromatase inhibitors in women with clomiphene citrate resistance: a randomized, double-blind, placebo-controlled trial.
Kamath MS; Aleyamma TK; Chandy A; George K
Fertil Steril; 2010 Dec; 94(7):2857-9. PubMed ID: 20638059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
